FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2323664694> ?p ?o ?g. }

• W2323664694 abstract "Background: NSCLC comprises 80% of lung cancer cases, and of these, about 40% are unresectable. Ionizing radiation (IR) and chemotherapy are used for patients with unresectable tumors, but radiotherapy remains largely palliative due to radioresistance. The failure of NSCLC therapy is associated with the tremendous heterogeneity in terms of cell of origin, pathology, etiology, and molecular/genetic pathogenesis. The existence of CSCs, undifferentiated cells with the capacity to self-renew and restore the tumor cell population, reflects the cellular heterogeneity within NSCLC. Evidence suggests that resistance to IR treatment is associated with CSCs within human tumors. Thus, targeting CSCs represents a new strategy for cancer treatment. We reported on our ability to isolate, culture and assay human lung CSCs from cultured cell lines. We found the stem cell factor (SCF) and its receptor c-kit functions, in a crucial pathway, for the self-renewal and proliferation of human lung CSCs. Hypothesis: CSCs survived after IR treatment of NSCLC cells. SCF/c-kit signaling is a central component of the self renewal and the survival of CSCs in lung tumors. The combination of IR treatment and c-kit pathway inhibition will eliminate bulk NSCLC cells and CSCs. Methods: CD133-positive and c-kit positive lung CSCs were isolated from H460 and A549 cultured NSCLC cell lines and from tumor samples from patients with NSCLC. The expression of cell surface markers, stemness of the cells and their resistance to IR were evaluated. Lung CSCs were treated with c-kit inhibitors and neutralizing SCF antibody and the growth of tumor spheres were assessed. Bulk NSCLC cells were irradiated and then were grown in the media with c-kit inhibitors and neutralizing SCF antibody for 3-12 days. The growing clones will then be counted and analyzed for expression of CSC markers. Cells from clones were re-plated and grown in stem cell-selective media and the CSC nature of the cells were analyzed. Results: We found that human lung CSC radioresistance is mediated by preferential activation of the DNA damage checkpoint response and an increase in DNA repair capacity. Tyrosine kinase inhibitors, with anti c-kit activity (eg.imatinib, dovitinib, sunitinib, and axitinib), were compared for their ability to abrogate lung CSC proliferation and potentiate the effect of IR on NSCLC. We found that lung CSCs proliferation was abrogated by all of the four c-kit inhibitors; however, axitinib showed the most profound anti- CSC effect. Conclusions: Targeting c-kit signaling, in c-kit and CD133-positive NSCLC cells with neutralizing SCF antibody or RTK inhibitors, suppressed CSC self renew and enhanced radiation response. The combination of IR treatment with SCF/c-kit pathway inhibition eliminated bulk NSCLC cells and radiation resistant CSCs. Work is supported by the grants: P50 CA090440 and The Pittsburgh Foundation (M2010-0021). Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3461. doi:1538-7445.AM2012-3461" @default.
• W2323664694 created "2016-06-24" @default.
• W2323664694 creator A5005651831 @default.
• W2323664694 creator A5008509483 @default.
• W2323664694 creator A5031746829 @default.
• W2323664694 creator A5035144823 @default.
• W2323664694 creator A5055217496 @default.
• W2323664694 creator A5075501671 @default.
• W2323664694 creator A5081494397 @default.
• W2323664694 date "2012-04-15" @default.
• W2323664694 modified "2023-10-02" @default.
• W2323664694 title "Abstract 3461: C-kit inhibitors and radiation: A promising combination in NSCLC" @default.
• W2323664694 doi "https://doi.org/10.1158/1538-7445.am2012-3461" @default.
• W2323664694 hasPublicationYear "2012" @default.
• W2323664694 type Work @default.
• W2323664694 sameAs 2323664694 @default.
• W2323664694 citedByCount "0" @default.
• W2323664694 crossrefType "proceedings-article" @default.
• W2323664694 hasAuthorship W2323664694A5005651831 @default.
• W2323664694 hasAuthorship W2323664694A5008509483 @default.
• W2323664694 hasAuthorship W2323664694A5031746829 @default.
• W2323664694 hasAuthorship W2323664694A5035144823 @default.
• W2323664694 hasAuthorship W2323664694A5055217496 @default.
• W2323664694 hasAuthorship W2323664694A5075501671 @default.
• W2323664694 hasAuthorship W2323664694A5081494397 @default.
• W2323664694 hasConcept C121608353 @default.
• W2323664694 hasConcept C126322002 @default.
• W2323664694 hasConcept C142724271 @default.
• W2323664694 hasConcept C2776256026 @default.
• W2323664694 hasConcept C28328180 @default.
• W2323664694 hasConcept C2908647359 @default.
• W2323664694 hasConcept C502942594 @default.
• W2323664694 hasConcept C509974204 @default.
• W2323664694 hasConcept C55427017 @default.
• W2323664694 hasConcept C58962609 @default.
• W2323664694 hasConcept C71924100 @default.
• W2323664694 hasConcept C86803240 @default.
• W2323664694 hasConcept C95444343 @default.
• W2323664694 hasConcept C99454951 @default.
• W2323664694 hasConceptScore W2323664694C121608353 @default.
• W2323664694 hasConceptScore W2323664694C126322002 @default.
• W2323664694 hasConceptScore W2323664694C142724271 @default.
• W2323664694 hasConceptScore W2323664694C2776256026 @default.
• W2323664694 hasConceptScore W2323664694C28328180 @default.
• W2323664694 hasConceptScore W2323664694C2908647359 @default.
• W2323664694 hasConceptScore W2323664694C502942594 @default.
• W2323664694 hasConceptScore W2323664694C509974204 @default.
• W2323664694 hasConceptScore W2323664694C55427017 @default.
• W2323664694 hasConceptScore W2323664694C58962609 @default.
• W2323664694 hasConceptScore W2323664694C71924100 @default.
• W2323664694 hasConceptScore W2323664694C86803240 @default.
• W2323664694 hasConceptScore W2323664694C95444343 @default.
• W2323664694 hasConceptScore W2323664694C99454951 @default.
• W2323664694 hasLocation W23236646941 @default.
• W2323664694 hasOpenAccess W2323664694 @default.
• W2323664694 hasPrimaryLocation W23236646941 @default.
• W2323664694 hasRelatedWork W1496178984 @default.
• W2323664694 hasRelatedWork W1599620353 @default.
• W2323664694 hasRelatedWork W1982890204 @default.
• W2323664694 hasRelatedWork W2005097948 @default.
• W2323664694 hasRelatedWork W2012306280 @default.
• W2323664694 hasRelatedWork W2068990310 @default.
• W2323664694 hasRelatedWork W2071015820 @default.
• W2323664694 hasRelatedWork W2072693879 @default.
• W2323664694 hasRelatedWork W2297970061 @default.
• W2323664694 hasRelatedWork W2333042222 @default.
• W2323664694 hasRelatedWork W2479069606 @default.
• W2323664694 hasRelatedWork W2495549112 @default.
• W2323664694 hasRelatedWork W2553901524 @default.
• W2323664694 hasRelatedWork W2567159246 @default.
• W2323664694 hasRelatedWork W2741737180 @default.
• W2323664694 hasRelatedWork W2787374821 @default.
• W2323664694 hasRelatedWork W2938397366 @default.
• W2323664694 hasRelatedWork W2966796137 @default.
• W2323664694 hasRelatedWork W2989722493 @default.
• W2323664694 hasRelatedWork W3015215657 @default.
• W2323664694 isParatext "false" @default.
• W2323664694 isRetracted "false" @default.
• W2323664694 magId "2323664694" @default.
• W2323664694 workType "article" @default.